High Dose Intravenous Vitamin C in Supportive Cancer Care
High dose Intravenous Vitamin C (HDIVC) aka Ascorbic Acid (AA) is gaining acceptance around the world in various cancer centers as an additive treatment in cancer therapy. New research from the National Institutes of Health in the United States has determined several mechanisms of actions leading to its anti cancer effects. Intravenous treatments with vitamin C can be used to enhance the effectiveness and reduce side effects of conventional treatments while potentially acting as an adjunctive chemotherapeutic agent.
Continue reading